1 / 28

Drug Safety in Pregnancy

Drug Safety in Pregnancy. Mother Child. Adverse Drug Reactions.

luisa
Télécharger la présentation

Drug Safety in Pregnancy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drug Safety in Pregnancy • Mother • Child

  2. Adverse Drug Reactions An appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product

  3. Adverse Drug Reactions • Common • 6.2% of all hospital admissions • >100,000 deaths in the US p.a. • Occupy 7 800-bed hospitals in the UK

  4. Drug Safety in Pregnancy • Pre-existing disorders, e.g. epilepsy • Infections, e.g. urinary tract infections • Disorders of pregnancy • Treatment of foetus

  5. Physiological changes in Pregnancy Absorption Decrease in intestinal motility Decreased gastric emptying Emesis/reflux - decreased absorption

  6. Physiological changes in Pregnancy Distribution Increased plasma volume by 45% (32 wks) Total body fat increased Protein concentration decreased Uterine blood flow increased (<1% to 16-25%)

  7. Physiological changes in Pregnancy • 50% Increase in glomerular filtration rate by mid pregnancy • Increased excretion of drugs, increased dose requirements Excretion

  8. Bacteriuria in pregnancy • 6% of normal pregnant women have asymptomatic bacteriuria • 23-40% of these will develop acute pyelonephritis • Screening at initial visit • E. coli commonest

  9. Bacteriuria in pregnancy Treatment • Asymptomatic Trial of single dose therapy If fails, 7-day course • Safe: Penicillins and nitrofurantoin • Contraindicated: Quinolones, tetracycline and trimethoprim

  10. Bacteriuria in pregnancy • Symptomatic UTI: 1-2% of pregnant women • Prevent complication to mother and foetus • Prevent recurrence • Ampicillin 10-14 day course Treatment

  11. Adverse Effects of Penicillins • Nausea • Pregnancy can cause nausea • UTI may cause nausea • Drug can cause nausea

  12. Adverse Effects of Penicillins • Diarrhoea • Vary in severity • Mild to fulminant colitis Pseudomembranous Colitis – Clostridium difficile

  13. Adverse Effects of Penicillins:Rash

  14. Causality • Pregnancy-related? • Disease-related? • Drug-related?

  15. Causality • Temporal relationship • Rechallenge • Exclusion of other causes • Previous reports • ALWAYS CONSIDER DRUGS IN DIFFERENTIAL DIAGNOSIS OF NEW SYMPTOMS

  16. Placental Circulation Maternal Foetal

  17. Placental transfer • Molecular weight of drug <500 daltons • Lipid solubility • Degree of ionisation of drug • Extent of plasma protein binding

  18. Placental transfer • Type I - equal concentrations complete transfer profile • Type II - higher foetal than maternal plasma concentrations • Type III - higher maternal concentrations; incomplete transfer profile

  19. Teratogenicity • Regard every drug as being potentially teratogenic • 1-5% of all congenital anomalies are caused by drugs • Thalidomide disaster • Yellow card adverse drug reaction reporting scheme

  20. YELLOW CARDS • Introduced in 1964 • 500,000 reports • ~ 20,000 reports per year

  21. Teratogenicity Screening for teratogenicity • Animals used as models for man • 2 species (rat or mouse and rabbit) • 3 dose levels • Period of organogenesis • Males tested for effect on fertility • Females administered drug in 3rd trimester to assess effects on foetal growth

  22. Teratogenicity • Period of organogenesis • Late stages may lead to fetal growth retardation and/or mental retardation Stage of pregnancy

  23. Teratogenicity • Alcohol • Anticonvulsants • Thalidomide • Corticosteroids • Vitamin A and derivatives

  24. Sources of Information

  25. Sources of information • Dug Information Centres • National Teratology Information Centre, The Regional Drug and Therapeutic Centre, Wolfson Unit, Claremont Place, Newcastle-upon-Tyne. Tel No. 0191 232 1525

  26. Prescribing in pregnancy • Disease pre-pregnancy - does drug therapy need to be continued? - does it need to be altered? • Try non-drug treatment first • Avoid multiple drugs • Select the safest and most efficacious drug • Dose changes may be necessary

  27. Adverse drug reaction in pregnancy • Consider stopping drug • Treat mother • If harm to the foetus suspected, get specialist advice • Communication with mother • Report the adverse reaction

More Related